The weekly litigation news digest is live. Subscribe now

IP Verse

Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To Leukocytes

Patent No. EP3303598 (titled "Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To Leukocytes") was filed by Ramot AT TEL Aviv University on May 25, 2016. The application was issued on Mar 19, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KARODec 18, 2025-
SANOFIDec 15, 2025CARPMAELS & RANSFORD
STRAWMANDec 15, 2025HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3303598

RAMOT AT TEL AVIV UNIVERSITY
Application Number
EP16799476A
Filing Date
May 25, 2016
Status
Granted And Under Opposition
Feb 14, 2025
Publication Date
Mar 19, 2025
External Links
Slate, EP3303598B1, Google Patents